Company ImpediMed Limited

Equities

IPD

AU000000IPD8

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. 02:10:52 2024-04-18 am EDT 5-day change 1st Jan Change
0.095 AUD +1.06% Intraday chart for ImpediMed Limited +2.15% -34.48%

Business Summary

ImpediMed Limited is an Australia-based medical software technology company. The Company is engaged in the development, manufacture, and sale of bioimpedance spectroscopy (BIS) systems and software services with a focus on the early detection of lymphoedema and heart failure. It measures, monitors and manages fluid status and tissue composition using BIS. The Company’s SOZO digital health platform uses BIS technology to measure and track critical information about the human body to aid clinicians in managing chronic disease and maximizing patient health. Its SFB7 measures fluid status and tissue composition for clinical and research applications. It offers ImpediVET, a single-channel, tetrapolar BIS device that measures fluid status and tissue composition for veterinary applications from laboratory research to clinic. SOZO applications include L-Dex Analysis for Lymphedema, BodyComp Analysis, Segmental BodyComp analysis, and HF-Dex analysis for heart failure.

Number of employees: 76

Sales per Business

AUD in Million2022Weight2023Weight Delta
SOZO Digital Health Platform
93.1 %
10 93.5 % 11 93.1 % +6.88%
Legacy
6.0 %
1 5.8 % 1 6.0 % +12.09%
Other
0.8 %
0 0.7 % 0 0.8 % +33.80%

Sales per region

AUD in Million2022Weight2023Weight Delta
North America
72.8 %
6 57.8 % 8 72.8 % +35.29%
Unallocated
18.0 %
3 31.6 % 2 18.0 % -38.90%
Australia/Rest of World
9.2 %
1 10.6 % 1 9.2 % -6.93%

Managers

Managers TitleAgeSince
Chief Executive Officer - Jan. 07
Director of Finance/CFO - 23-09-27
Chief Tech/Sci/R&D Officer - 23-09-25
Chief Tech/Sci/R&D Officer - 07-09-30
Investor Relations Contact - 19-12-31
Sales & Marketing - -
Sales & Marketing - 19-02-28
Corporate Officer/Principal - 18-07-01
Human Resources Officer - 16-06-30
Corporate Secretary - -

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer - Jan. 07
Director of Finance/CFO - 23-09-27
Chairman - 23-09-27
Director/Board Member - 23-09-27
Director/Board Member - 23-09-27

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,023,307,922 1,734,763,834 ( 85.74 %) 0 85.74 %

Shareholders

NameEquities%Valuation
Paradice Investment Management Pty Ltd.
8.610 %
174,188,828 8.610 % 10 M $
Australian Ethical Investments Ltd. (Investment Management)
5.699 %
115,304,879 5.699 % 7 M $
Acadia Park Pty Ltd.
4.979 %
100,737,200 4.979 % 6 M $
MBA Investments Pty Ltd.
1.112 %
22,490,990 1.112 % 1 M $
21,263,705 1.051 % 1 M $
Greg Brown
1.043 %
21,100,000 1.043 % 1 M $
Sunlora Pty Ltd.
0.9392 %
19,000,000 0.9392 % 1 M $
Apex Investment Management Pty L
0.8636 %
17,471,778 0.8636 % 1 M $
Pakasoluto Pty Ltd.
0.7914 %
16,011,422 0.7914 % 961 006 $
16,000,000 0.7909 % 960 320 $

Company contact information

ImpediMed Ltd.

50 Parker Court Unit 1

4008, Pinkenba

+

http://www.impedimed.com
address ImpediMed Limited(IPD)
  1. Stock Market
  2. Equities
  3. IPD Stock
  4. Company ImpediMed Limited